BCAL Diagnostics Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating industry group for BCAL Diagnostics Ltd are shown below. Browse to the end of the page for potential risks for BCAL Diagnostics Ltd based on sector, geography and size. This page includes a questions and answers section about BCAL Diagnostics Ltd.
BCAL Diagnostics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 8.0 and governance score of 2.7.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | BCAL Diagnostics Ltd | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does BCAL Diagnostics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes BCAL Diagnostics Ltd report the average age of the workforce?
Sign up for free to unlockDoes BCAL Diagnostics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes BCAL Diagnostics Ltd offer flexible work?
Sign up for free to unlockDoes BCAL Diagnostics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes BCAL Diagnostics Ltd conduct supply chain audits?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes BCAL Diagnostics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose water use targets?
Sign up for free to unlockDoes BCAL Diagnostics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid BCAL Diagnostics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes BCAL Diagnostics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas BCAL Diagnostics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes BCAL Diagnostics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes BCAL Diagnostics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs BCAL Diagnostics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose its waste policy?
Sign up for free to unlockDoes BCAL Diagnostics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose energy use targets?
Sign up for free to unlockDoes BCAL Diagnostics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes BCAL Diagnostics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for BCAL Diagnostics Ltd
These potential risks are based on the size, segment and geographies of the company.
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.